TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JBJ Medicine etc. AB
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 0 | 4 | 0 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -2 | 1 | -2 |
EBITDA | -2 | 1 | -2 |
Total assets | 5 | 9 | 7 |
Current assets | 2 | 5 | 1 |
Current liabilities | 1 | 3 | 2 |
Equity capital | 4 | 6 | 5 |
- share capital | 4 | 5 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 80.0% | 66.7% | 71.4% |
Turnover per employee | 0 | 4 | 0 |
Profit as a percentage of turnover | 25.0% | ||
Return on assets (ROA) | -40.0% | 11.1% | -28.6% |
Current ratio | 200% | 166.7% | 50.0% |
Return on equity (ROE) | -50.0% | 16.7% | -40.0% |
Change turnover | -3 | 4 | -2 |
Change turnover % | -100% | -100% | |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.